NMR Spectroscopy in RNA Drug Discovery
About This Webcast
This presentation will overview the versatile roles of NMR spectroscopy in RNA drug discovery for providing the structural basis for the rational drug design. Advanced techniques for simplifying crowded spectra of large RNAs will be discussed. A disease-related RNA and small molecule structural study will be included as an example to elaborate how NMR techniques are employed to tackle challenges in drug discovery. Key Learning Points NMR in RNA target characterization NMR in RNA structure determination NMR in RNA-small molecule engagement
Speakers
Dr. Yaqiang Wang
Principal Scientist , Arrakis Therapeutics
Dr. Yaqiang Wang is a Principal Scientist in Structural biology at Arrakis Therapeutics, and a structural biology lead of RNA and small molecule characterization. Yaqiang received postdoctoral training at University of California Los Angles with Prof. Juli Feigon after his PhD at University of North Carolina at Chapel Hill with Prof. Gary Pielak.
Dr. Martial Piotto
Pharma product manager of Biologics solutions , Bruker BioSpin
Martial Piotto obtained his Ph.D. in NMR spectroscopy at the University of Purdue, USA (Pr. D. Gorenstein). He then joined Bruker France as head of NMR application. In this position, he worked on various aspects of NMR spectroscopy but was particularly involved in the development of new pulse sequences and on the development of HRMAS technology. Over the years, he grew an interest in new applications of NMR in the pharmaceutical and in the medical fields. His work currently focusses on the characterization of Biologics (mAb and vaccines) by combining NMR and multivariate statistical tools.